Abstract

Paracrine signaling through receptor activator of NF-κB (RANK) pathway mediates the expansion of mammary epithelia that occurs during pregnancy, and activation of RANK pathway promotes mammary tumorigenesis in mice. In this study we extend these previous data to human cells and show that the RANK pathway promotes the development of mammary stem cells and breast cancer. Overexpression of RANK (FL-RANK) in a panel of tumoral and normal human mammary cells induces the expression of breast cancer stem and basal/stem cell markers. High levels of RANK in untransformed MCF10A cells induce changes associated with both stemness and transformation, including mammary gland reconstitution, epithelial-mesenchymal transition (EMT), increased migration, and anchorage-independent growth. In addition, spheroids of RANK overexpressing MCF10A cells display disrupted acinar formation, impair growth arrest and polarization, and luminal filling. RANK overexpression in tumor cells with nonfunctional BRCA1 enhances invasiveness in acinar cultures and increases tumorigenesis and metastasis in immunodeficient mice. High levels of RANK were found in human primary breast adenocarcinomas that lack expression of the hormone receptors, estrogen and progesterone, and in tumors with high pathologic grade and proliferation index; high RANK/RANKL expression was significantly associated with metastatic tumors. Together, our findings show that RANK promotes tumor initiation, progression, and metastasis in human mammary epithelial cells by increasing the population of CD44(+)CD24(-) cells, inducing stemness and EMT. These results suggest that RANK expression in primary breast cancer associates with poor prognosis.

Highlights

  • Receptor activator of NF-kB (RANK) ligand (RANKL) and its receptor RANK, members of the TNF ligand and receptor super family, respectively, are key regulators of bone remodeling and metastasis [1], and mammary gland development [2]

  • RANK overexpression induces epithelial–mesenchymal transition (EMT) in nontranformed human mammary epithelial cells To evaluate the impact of RANK overexpression in human mammary epithelial cells, we obtained stable MCF10A cells, 2880 Cancer Res; 72(11) June 1, 2012

  • We show that RANK overexpression in human MCF10A cells results in constitutive activation of the pathway shown by the increased levels of RANK downstream targets (P-Ikba, P-p38, P-Akt, and P-Erk)

Read more

Summary

Introduction

Receptor activator of NF-kB (RANK) ligand (RANKL) and its receptor RANK, members of the TNF ligand and receptor super family, respectively, are key regulators of bone remodeling and metastasis [1], and mammary gland development [2]. Impaired mammary gland development of the RANK and RANKL null mice is due to defective proliferation and increased apoptosis of mammary epithelium [2]. Overexpression of RANK or RANKL in the mammary gland leads to increased. Note: Supplementary data for this article are available at Cancer Research Online (http://cancerres.aacrjournals.org/). We and others have recently shown that activation of RANK signaling promotes mammary tumorigenesis in mice [4, 7, 8]. MMTV-RANK transgenic mice are prone to mammary tumors [4, 7]. Pharmacologic inhibition of RANKL or genetic ablation of RANK attenuates mammary tumor development [7, 8]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call